PTX3 and coronary artery disorder: On one side, PTX3 reduces inflammation, reduces macrophages infiltration, lowers the myocardial necrosis, and decreases the risk of coronary restenosis, and on the other side, it induces morphological alterations, increases blood pressure levels, increases the prevalence of coronary artery disease, and increases fibroblast growth factor 2 and tissue factor expression [88].